1. Academic Validation
  2. Temporal Contribution of Myeloid-Lineage TLR4 to the Transition to Chronic Pain: A Focus on Sex Differences

Temporal Contribution of Myeloid-Lineage TLR4 to the Transition to Chronic Pain: A Focus on Sex Differences

  • J Neurosci. 2021 May 12;41(19):4349-4365. doi: 10.1523/JNEUROSCI.1940-20.2021.
Nolan A Huck 1 Janelle Siliezar-Doyle 1 Elena S Haight 1 Ryosuke Ishida 1 2 Thomas E Forman 1 Shaogen Wu 1 Huaishuang Shen 1 3 Yoshinori Takemura 1 4 J David Clark 1 Vivianne L Tawfik 5
Affiliations

Affiliations

  • 1 Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, California 94305.
  • 2 Department of Anesthesiology, Shimane University, Shimane, Japan 690-0823.
  • 3 Department of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China 215000.
  • 4 Department of Anesthesiology, University of Toyama, Toyama, Japan 930-8555.
  • 5 Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, California 94305 vivianne@stanford.edu.
Abstract

Complex regional pain syndrome (CRPS) is a chronic pain disorder with a clear acute-to-chronic transition. Preclinical studies demonstrate that Toll-like Receptor 4 (TLR4), expressed by myeloid-lineage cells, astrocytes, and neurons, mediates a sex-dependent transition to chronic pain; however, evidence is lacking on which exact TLR4-expressing cells are responsible. We used complementary pharmacologic and transgenic approaches in mice to more specifically manipulate myeloid-lineage TLR4 and outline its contribution to the transition from acute-to-chronic CRPS based on three key variables: location (peripheral vs central), timing (prevention vs treatment), and sex (male vs female). We demonstrate that systemic TLR4 antagonism is more effective at improving chronic allodynia trajectory when administered at the time of injury (early) in the tibial fracture model of CRPS in both sexes. In order to clarify the contribution of myeloid-lineage cells peripherally (macrophages) or centrally (microglia), we rigorously characterize a novel spatiotemporal transgenic mouse line, Cx3CR1-CreERT2-eYFP;TLR4fl/fl (TLR4 cKO) to specifically knock out TLR4 only in microglia and no other myeloid-lineage cells. Using this transgenic mouse, we find that early TLR4 cKO results in profound improvement in chronic, but not acute, allodynia in males, with a significant but less robust effect in females. In contrast, late TLR4 cKO results in partial improvement in allodynia in both sexes, suggesting that downstream cellular or molecular TLR4-independent events may have already been triggered. Overall, we find that the contribution of TLR4 is time- and microglia-dependent in both sexes; however, females also rely on peripheral myeloid-lineage (or other TLR4 expressing) cells to trigger chronic pain.SIGNIFICANCE STATEMENT The contribution of myeloid cell TLR4 to sex-specific pain progression remains controversial. We used complementary pharmacologic and transgenic approaches to specifically manipulate TLR4 based on three key variables: location (peripheral vs central), timing (prevention vs treatment), and sex (male vs female). We discovered that microglial TLR4 contributes to early pain progression in males, and to a lesser extent in females. We further found that maintenance of chronic pain likely occurs through myeloid TLR4-independent mechanisms in both sexes. Together, we define a more nuanced contribution of this receptor to the acute-to-chronic pain transition in a mouse model of complex regional pain syndrome.

Keywords

CRPS; TLR4; microglia; myeloid; pain; sex differences.

Figures
Products